XGN
Exagen Inc
NASDAQ: XGN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$2.90
+5.07% today
Updated 2026-04-30
Market cap
$65.91M
P/E ratio
—
P/S ratio
0.99x
EPS (TTM)
$-0.93
Dividend yield
—
52W range
$3 – $12
Volume
0.3M
Exagen Inc (XGN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-30.00%
Operating margin
-29.90%
ROE
-147.80%
ROA
-17.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $926000.00 | $-7.32M | -113.17% | -737.15% | -790.93% |
| 2013 | $3.06M | $-13.50M | 7.36% | -299.31% | -441.77% |
| 2014 | $11.66M | $-14.98M | 40.97% | -99.08% | -128.45% |
| 2015 | $17.95M | $-19.18M | 46.88% | -57.88% | -106.89% |
| 2017 | $26.81M | $-25.63M | 47.26% | -29.23% | -95.61% |
| 2018 | $32.44M | $-8.01M | 52.59% | -15.04% | -24.70% |
| 2019 | $40.39M | $-12.04M | 53.43% | -23.02% | -29.81% |
| 2020 | $41.98M | $-16.69M | 60.55% | -36.18% | -39.75% |
| 2021 | $48.30M | $-26.85M | 57.37% | -49.83% | -55.59% |
| 2022 | $45.56M | $-47.39M | 46.86% | -101.07% | -104.00% |
| 2023 | $52.55M | $-23.69M | 56.06% | -43.46% | -45.08% |
| 2024 | $55.64M | $-15.12M | 59.51% | -24.51% | -27.17% |
| 2025 | $66.58M | $-19.95M | 58.28% | -21.13% | -29.97% |